-
Novavax Stock Faces Retail Backlash As Shah Capital Warns Of Proxy Fight And Presses For A Sale
13 Nov 2025 03:57 GMT
… disappointing commercial performance of Novavax’s vaccine, which sold … doses sold by two competitors over the same period. … Stocktwits, retail sentiment for Novavax was ‘neutral’ amid ‘ … StocktwitsOne user argued that Novavax’s leadership had mishandled the …
-
Shah Capital pushes for Novavax sale, warns of proxy fight
13 Nov 2025 00:13 GMT
…
(Reuters) -Shah Capital, Novavax’s second-largest shareholder, is … underperforming,” the letter said.
Novavax’s vaccine sold about … same period by two competitors, leaving Novavax’s market share … .
Earlier this month, Novavax pushed back its profitability …
-
Novavax, Inc. (NASDAQ:NVAX) Q3 2025 Earnings Call Transcript
07 Nov 2025 13:50 GMT
… terms. This transaction supports Novavax’s financial strength during … updates as we improve Novavax’s financial performance, cost … very similar with what competitors have used in their … disconnect.
Follow Novavax Inc (NASDAQ:NVAX) Follow Novavax Inc (NASDAQ …
-
Shah Capital urges sale of Novavax amid continued vaccine sales struggles
15 Oct 2025 20:10 GMT
… the board, Shah Capital, Novavax’s second-largest shareholder, … million shots distributed by mRNA competitors Pfizer and Moderna, which … the right marketing strategy, Novavax’s market share could … as potential buyers for Novavax, while clarifying that he …
-
Hedge Fund Shah Capital Urges Novavax To Consider Sale Amid Vaccine Rollout Struggles, Sees $5 Billion Potential
14 Oct 2025 18:44 GMT
Shah Capital is reportedly pressing Novavax Inc. (NASDAQ:NVAX) … be potential buyers for Novavax.
Himanshu Shah, founder and … compared with competitors.
As of Oct. 2, Novavax had distributed … candidate in July.
Leveraging Novavax's recombinant, protein …
-
FDA approves Novavax COVID shot
20 May 2025 17:57 GMT
… .
Vaccines made by Novavax’s competitors Pfizer and Moderna already … at higher risk. The Novavax decision suggests the Trump … and other Trump officials.
Novavax originally showed its vaccine … discuss confidential agency matters.
Novavax later announced the FDA …
-
STAT+: Pharmalittle: We’re reading about Regeneron buying 23andMe, the Novavax Covid shot, and more
19 May 2025 20:05 GMT
… Drug Administration has finally approved Novavax’s Covid-19 vaccine, but … on it that its two competitors in the U.S. market … 1 deadline to rule on Novavax’s application and it was … that the clinical trials supporting Novavax’s application had been done …
-
Novavax jumps on long-awaited FDA approval for COVID vaccine
19 May 2025 11:25 GMT
… in a CBS interview. Novavax missed out on the pandemic … 175 million milestone payment to Novavax from Sanofi, related to … pending strain recommendation. Novavax, along with its competitors, will need to … week. Through last close, Novavax shares have fallen 16. …
-
New Novavax Covid -19 vaccine tailored for patients 65 and older
18 May 2025 22:19 GMT
… vaccine produced by pharmaceutical giant Novavax.
That sets aside from the … News, vaccines made by Novavax’s competitors Pfizer and Moderna already are …
-
Novavax COVID-19 shot wins full license with tight age, risk restrictions from FDA
18 May 2025 08:00 GMT
… AD
Vaccines made by Novavax’s competitors Pfizer and Moderna … at higher risk. The Novavax decision suggests the Trump … and other Trump officials.
Novavax originally showed its vaccine was … been on track to grant Novavax full approval – without restrictions …